Journal of Cancer

Papers
(The H4-Index of Journal of Cancer is 30. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
High Expression of RhoF Predicts Worse Overall Survival: A Potential Therapeutic Target for non-M3 Acute Myeloid Leukemia: Erratum85
The impacts of MACC1 gene polymorphisms on urothelial cell carcinoma susceptibility and clinicopathologic characteristics in Taiwan73
Salmonella-induced inhibition of β3-adrenoceptor expression in tumors and reduces tumor metastasis64
Development of A Nomogram for Progression-free Survival in Patients with Stage II/T3N0 Nasopharyngeal Carcinoma to Explore Different Treatment Modalities50
Drugging the tumor microenvironment epigenome for therapeutic interventions in NSCLC49
HER4 Promotes Osteosarcoma Progression and Predicts Poor Prognosis through the PTEN-PI3K/AKT Pathway: Retraction48
Spermidine potentiates anti-tumor immune responses and immunotherapy sensitivity in breast cancer46
The significance of HAUS1 and its relationship with immune microenvironment in hepatocellular carcinoma45
Tanshinone IIA inhibits cell viability and promotes PUMA-mediated apoptosis of oral squamous cell carcinoma45
Screening of PDSS1 as a Potential Biomarker for Hepatocellular Carcinoma Based on a Copper-Related Prognostic Signature through Bulk and Single-cell RNA-sequencing Analysis45
WEE1 Inhibitors Mediate Antitumor Effects on Endometrial Cancer through Activation of Innate Immune Responses44
The immediate risk of cancer and its precursor lesions in women with abnormal cervical glandular cytology43
Differential diagnosis of benign and malignant ovarian tumors with combined tumor and systemic inflammation-related markers42
Neoadjuvant Chemotherapy Can Effectively Avoid Unnecessary Extended Resection for Gastric Cancer with Clinical Evidence of Duodenum or Pancreas Head Involvement42
Anti-CD47 Antibody Enhances the Efficacy of Chemotherapy in Patients with Gastric Cancer Liver Metastasis41
Insight into the Role of the BCL6B Gene in Biological Functions and Disease Progression41
NEK6 functions as an oncogene to promote the proliferation and metastasis of ovarian cancer41
WTAP regulates Mitochondrial damage and Lipid oxidation in HCC by NOA1 mediated m6A modification40
CSNK1G2-AS1 promotes metastasis, colony formation and serves as a biomarker in testicular germ cell tumor cells38
PPP1R14B as a potential biomarker for the identification of diagnosis and prognosis affecting tumor immunity, proliferation and migration in prostate cancer38
Potential clinical treatment prospects behind the molecular mechanism of alternative lengthening of telomeres (ALT)36
LncRNA LINC00460 facilitates the proliferation and metastasis of renal cell carcinoma via PI3K/AKT signaling pathway36
Anisomycin has a potential toxicity of promoting cuproptosis in human ovarian cancer stem cells by attenuating YY1/lipoic acid pathway activation35
Dimethoxytolyl propylresorcinol induces apoptosis and mitophagy in human leukemia cells through the PI3K/AKT pathway33
The Role of Cathepsin B in Pathophysiologies of Non-tumor and Tumor tissues: A Systematic Review31
The Functional Role of LncRNA UCA1 in Pancreatic Cancer: a mini-review31
A Potential biomarker for the early diagnosis of OSCC: saliva and serum PrPC31
Pan-Cancer Analysis of KANK2: Clinical and Molecular Insights into Tumor Progression and Therapeutic Implications30
LncRNA HOTAIR Enhances Epithelial-to-mesenchymal Transition to Promote the Migration and Invasion of Liver Cancer by Regulating NUAK1 via Epigenetic Inhibition miR-145-5p Expression30
PPAR-δ as a prognostic biomarker and its association with immune infiltrates in breast cancer PPAR-δ as a prognostic biomarker and its association with immune infiltrates in breast cancer30
The Role of CTNNA1 in Malignancies: An Updated Review30
CDH3 Is an Effective Serum Biomarker of Colorectal Cancer Distant Metastasis Patients30
0.30076003074646